1 CONFIDENTIAL TREATMENT EXHIBIT 10.3 LICENSE AGREEMENT Effective as of January 2, 1995 ("Effective Date"), THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California...License Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • California
SERVICE AGREEMENTService Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
MORRELL, PEEL & GAMLEN -Solicitors- 1 St Giles Oxford OX1 3JR 2 THIS AGREEMENT dated 6 October 1994 ("the Effective Date") is made between:Leukosite Inc • August 13th, 1997 • Pharmaceutical preparations
AGREEMENT OF LIMITED PARTNERSHIP OF L & I PARTNERS, L.P.Leukosite Inc • August 13th, 1997 • Pharmaceutical preparations • Delaware
EXHIBIT 10.17(b) LICENSE AGREEMENT This Agreement is effective May 2, 1997 ("the Effective Date") by and between LeukoSite, Inc. ("LKS"). a Delaware corporation having an address at 215 First Street, Cambridge, MA 02142, and L & I Partners, L.P., a...Confidential Treatment • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
LEUKON, INC. CONSULTING AGREEMENTConsulting Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
C) OA's combinatorial chemistry techniques are still experimental, therefore preparation of the library compounds identified in Appendix B may require a substantial amount to research and development work on the part of OA. Accordingly, OA cannot...Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
RESEARCH AGREEMENTResearch Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • England
1 CONFIDENTIAL TREATMENT EXHIBIT 10.8(a) LICENCE AGREEMENT (DOCUMENT IDENTIFICATION CODE: LEUKOSITE/IC/NHLI/0012/LICENCE) THIS AGREEMENT (hereinafter called the "LICENCE AGREEMENT") is made effective the Thirty First day of January, 1996 (hereinafter...Licence Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
1 CONFIDENTIAL TREATMENT EXHIBIT 10.5 LICENSE AGREEMENT This Agreement is effective March 15, 1995 ("EFFECTIVE DATE") by and between Lynxvale Ltd., having an address at the Old Schools, Cambridge CB2, ITS, England ("LYNXVALE"). and LeukoSite, Inc., a...License Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • England
COMMON STOCKLeukosite Inc • August 13th, 1997 • Pharmaceutical preparations • Massachusetts
1 CONFIDENTIAL TREATMENT EXHIBIT 10.9 RESEARCH COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • New York
The terms used in this Agreement have the following meaning: 2 -2-Research Collaboration and License Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
WITNESSETH:Development and Marketing Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations • Massachusetts
Critical Information" means that information and material listed in the Material Release Agreement of even date hereof between The Wellcome Foundation Ltd. and Leukosite, Inc. 2 -2-Leukosite Inc • August 13th, 1997 • Pharmaceutical preparations
2- 3 1.5 Annexed to this Agreement is Schedule 1: Critical Information.Material Release Agreement • August 13th, 1997 • Leukosite Inc • Pharmaceutical preparations
